Sentrimed
Mullica Hill, US · Founded 2023 · Delaware corporation
Founders & leadership
AR
Arye RosenExecutive
JG
Jack GoldbergExecutive
MR
Mari Rhodehamel YinExecutive
GG
Gary GoldbergExecutive
WR
William RagatzExecutive
CL
Christopher LeonardExecutive
Board
BG
Bradley GalerBoard director
TD
Tabbetha DobbinsBoard director
Reported raises · per SEC filings
Form D private placements$750K disclosed across 2 rounds · 2024–2026
▶$250KraisedMay 2026 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Arye RosenExecutive Officer
- Jack GoldbergExecutive Officer, Director
- Mari Rhodehamel YinExecutive Officer, Director
- Gary GoldbergExecutive Officer
- William RagatzExecutive Officer, Director
- Christopher LeonardExecutive Officer
- Bradley GalerDirector
- Tabbetha DobbinsDirector
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$500KraisedMar 2024 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tabbetha DobbinsDirector
- Mari Rhodehamel YinExecutive Officer, Director
- Arye RosenExecutive Officer
- William RagatzExecutive Officer, Director
- Jack GoldbergExecutive Officer, Director
- Bradley GalerDirector
- Gary GoldbergExecutive Officer
- Christopher LeonardExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $500K
- Minimum investment
- $25K
- Proceeds to insiders
- $100K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sentrimed raised?
- Sentrimed has disclosed $750K raised across 2 rounds.
- Where is Sentrimed headquartered?
- Sentrimed is headquartered in Mullica Hill, US.